Form D · Pharmaceuticals
PERNIX THERAPEUTICS HOLDINGS, INC.
The Woodlands, TX · CIK 0001024126
Offering snapshot reported Jan 8, 2013 · SEC filing
- Reported sold
- $34M Offering amount: $34M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2013 | Initial | $34,000,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-189722
See Item 10.
Source: Form D, filed Jan 8, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Becker | Executive |
| Anthem Blanchard | Director |
| Tracy Clifford | Executive |
| Cooper Collins | Director, Executive |
| Steven Elms | Director |
| Michael Pearce | Director |
| James Smith | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10003 Woodloch Forest Drive
The Woodlands, TX, 77380
The Woodlands, TX, 77380